◼ Archived
Business
🔮 fades ✓
Hims & Hers CEO says FTC lawsuit misunderstands how the company works
Hims & Hers faces legal challenges from multiple fronts, including the FTC and the state of Utah.
Hims & Hers
5 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Hims & Hers
This hub groups 5 separate news trends connected to Hims & Hers, spanning July 8, 2026 through August 18, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 47 article observations and 45 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
EXCLUSIVE: US FTC sues Hims & Hers for sending user health info to Meta, Snap
The US Federal Trade Commission's lawsuit against Hims & Hers for sharing user health data with Meta and Snap puts telehealth privacy in the spotlight.
◼ Archived
Business
🔮 fades ✓
Hims & Hers targeted in FTC lawsuit (update) (HIMS:NYSE)
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 holds ✓
A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda
The FDA is reviewing the regulatory status of seven popular peptides used for weight loss, healing, and longevity.
◼ Archived
Health
🔮 fades ✗
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs
Employers and public health programs are limiting access to GLP-1 obesity drugs due to rising costs and budget constraints.